Impact of C-arm CT in Decreased Renal Function Undergoing TACE for Tx of Hepato-Cellular Carcinoma
Terminated
- Conditions
- Kidney (Renal Cell) Cancer
- Registration Number
- NCT01326390
- Lead Sponsor
- Stanford University
- Brief Summary
Impact on contrast dose or total volume of contrast required to effectively treat the targeted tumor.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- TERMINATED
- Sex
- All
- Target Recruitment
- 13
Inclusion Criteria
- Patients must be affected by HCC
- Patients must have diminished renal function (GFR<60 ml/min/1.73m^2)
- Patients must be 18 years old or older
- Patients must have received an abdominal CT, PET/CT scan or MRI, completed prior to the TACE procedure.
- Ability to understand and the willingness to sign a written informed consent document.
Read More
Exclusion Criteria
- Subjects under the age of 18
- Patients currently on dialysis
- Pregnant women
Read More
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Proportion of patients that develop renal failure (defined as a decline of renal function, as measured by glomerular filtration rate, of 25% or more from pre-procedural) 3 weeks
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Stanford University School of Medicine
🇺🇸Stanford, California, United States